Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

1 May 2014 07:00

RNS Number : 9946F
Kingspan Group PLC
01 May 2014
 



 

KINGSPAN GROUP PLC

Interim Management Statement

1st May 2014

 

Kingspan Group plc, the global leader in high performance insulation, building fabric and solar integrated building envelopes, is issuing this Interim Management Statement in advance of its Annual General Meeting which is being held today at 10.00am in Dublin.

 

Overall Kingspan has experienced a strong start to the year with Continental Europe showing tentative signs of recovery, and the UK market being relatively buoyant across all key sectors we serve. Group sales of €561m in the first four months were 8% ahead of prior year, or 9% ahead at constant exchange rates.

 

The general pick-up in activity in the UK, which we saw in the final quarter of 2013, has continued into the early part of 2014. The Benelux market has shown early signs of recovery although industry activity is at relatively low levels, and Germany remains solid. In North America, our Insulated Panel business continues to advance driven by market penetration gains, however there is limited evidence of a wider market recovery in that region. The Middle East continues to be quite active, and Australia started the year well as penetration continues to grow.

 

Insulated Panel sales revenues were up 14% (+16% constant currency) in the first four months with all key markets recording growth, reflecting both penetration gains and increased market activity, compounded by a mild winter in Europe. The sales performance also reflects a good first quarter from Kingspan Energy which should be well positioned to deliver its full year sales target. In February, we completed the acquisition of Dri-Design®, a high-end architectural façades business in the US with annual revenues of c. $25m.

 

Insulation Board sales revenues were 3% ahead (+3% constant currency) in the first four months reflecting a busier UK market and an improving environment in the Benelux, albeit off a low base. The Group's next generation Insulation, Optim-R®, entered production in the UK during the period, and a new insulation board facility in Burkhardtsdorf in eastern Germany is scheduled to be fully commissioned by mid-year.

 

Access Floor sales revenues were 9% behind (-7% constant currency) in the first four months. UK sales were ahead, driven by a lively London office market, countered by a US office environment which is stubbornly slow to recover. There is some evidence of a potential improvement in office activity in the US for 2015.

 

Environmental sales revenues in the four month period were in line with the same period last year, as the divisional activity enters a more stable phase.

 

Net debt at the 25th April was €124m an increase of €16m from the position at last year end reflecting, in part, the US façades acquisition for €23.2m. The Group's funding position is robust and, as announced recently, was further helped by the recent re-pricing and term extension of the Group's syndicated bank facility to March 2019.

 

The Board wishes to thank David Byrne and Brian Hill who will retire today as Non-Executive Directors. We are very grateful to both David and Brian for their counsel and contribution to the Board during the past nine years.

 

Looking ahead, the order backlog across the Group points towards a strong first half for the business, albeit somewhat complimented by a favourable quarter one comparative, ahead of a more demanding second quarter comparison. Activity levels generally across our markets are encouraging. We remain mindful of the prevailing geo-political uncertainty and its potential to upset what has so far been a relatively nebulous recovery. Notwithstanding this, growing conversion, a strong innovation pipeline, and the greater worldwide focus on energy efficiency, leaves us confident about Kingspan's longer term future.

 

Kingspan will issue its half-year financial report for the period ended 30 June 2014 on Tuesday 26 August 2014.

 

For further information contact:

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

Pat Walsh, Murray Consultants Tel: +353 (0) 1 4980300

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDSRXXBGSG
Date   Source Headline
27th Feb 20185:03 pmRNSDirector/PDMR Shareholding
27th Feb 20189:53 amRNSHolding(s) in Company
26th Feb 20184:55 pmRNSDirector/PDMR Shareholding
23rd Feb 20187:00 amRNSFinal Results
22nd Feb 20182:58 pmRNSDirectorate Change
20th Feb 20182:33 pmRNSHolding(s) in Company
2nd Jan 201810:30 amRNSBlock listing Interim Review
2nd Jan 201810:00 amRNSTotal Voting Rights
15th Dec 20172:02 pmRNSAcquisition
15th Dec 20172:00 pmRNSInvestment Update
4th Dec 20179:31 amRNSTotal Voting Rights
13th Nov 20175:13 pmRNSReplacement - Director/PDMR Shareholding
13th Nov 20177:00 amRNSTrading Update
13th Oct 20172:39 pmRNSDirector/PDMR Shareholding
10th Oct 20179:52 amRNSHolding(s) in Company
2nd Oct 20174:37 pmRNSDirector/PDMR Shareholding
2nd Oct 20174:31 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
27th Sep 20172:46 pmRNSHolding(s) in Company
27th Sep 20172:46 pmRNSHolding(s) in Company
27th Sep 20177:00 amRNSAcquisition
15th Sep 201710:04 amRNSHolding(s) in Company
12th Sep 20174:55 pmRNSDirector/PDMR Shareholding
1st Sep 20175:47 pmRNSTotal Voting Rights
29th Aug 20177:00 amRNSHolding(s) in Company
23rd Aug 20175:17 pmRNSHolding(s) in Company
18th Aug 20177:00 amRNSHalf-year Report
3rd Jul 20174:15 pmRNSBlock listing Interim Review
3rd Jul 20174:09 pmRNSTotal Voting Rights
28th Jun 20173:54 pmRNSHolding(s) in Company
26th Jun 201712:24 pmRNSCompletion of EUR500m Revolving Credit Facility
13th Jun 20179:40 amRNSHolding(s) in Company
7th Jun 20175:37 pmRNSDirector/PDMR Shareholding
2nd Jun 201712:05 pmRNSHolding(s) in Company
1st Jun 20179:36 amRNSTotal Voting Rights
12th May 20172:25 pmRNSHolding(s) in Company
8th May 201710:16 amRNSDirector/PDMR Shareholding
2nd May 20172:07 pmRNSBroker Appointment
2nd May 20179:47 amRNSTotal Voting Rights
28th Apr 20172:36 pmRNSHolding(s) in Company
27th Apr 201711:36 amRNSResult of AGM
27th Apr 20177:00 amRNSTrading Statement
13th Apr 201710:49 amRNSHolding(s) in Company
3rd Apr 20179:53 amRNSTotal Voting Rights
30th Mar 201711:03 amRNSDirector/PDMR Shareholding
30th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 201712:53 pmRNSHolding(s) in Company
22nd Mar 20175:01 pmRNSHolding(s) in Company
21st Mar 201710:04 amRNSDirector/PDMR Shareholding
20th Mar 201712:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.